Pharmaceuticals

Amgen said to raise bid for Onyx Pharma to $130 a share

07 Aug 2013

SC slams government for poor drug pricing policy

07 Aug 2013

German generic drugmaker Stada in talks to buy UK’s Thornton & Ross

06 Aug 2013

Nova Diabetes Care recalls 62 mn faulty glucose test strips

02 Aug 2013

India revokes patent of GSK’s breast cancer drug Tykerb

02 Aug 2013

The Intellectual Property Appellate Board, however, upheld the patent granted to the drug’s active pharmaceutical ingredient `lapatinib`

KKR & Co to buy ReSearch Pharmaceutical from PE firm Warburg

01 Aug 2013

US biopharma firm Cubist to buy pharma firms Trius, Optimer in $1.60-bn deal

31 Jul 2013

US drugmaker Perrigo buys Irish biotechnology major Elan for $8.6 bn

30 Jul 2013

The deal brings an end the multiple hostile attempts by US investment firm Royalty Pharma for the takeover of Elan during the past few months

Pfizer plans separate segments for brands, innovations and generics

29 Jul 2013

GSK to pay $229 mn to eight US states to settle diabetes drug Avandia lawsuits

25 Jul 2013

Pharma giants target biotech firm Onyx

23 Jul 2013

Chilean drugmaker CFR to raise $750 mn to fund Adcock Ingram acquisition

23 Jul 2013

EU regulator conditionally approves Baxter’s $4-bn Gambro acquisition

23 Jul 2013

Bain Capital buys majority stake in Plasma Resources UK for $349 mn

19 Jul 2013

Abbott to enter laser cataract surgery market through OptiMedica acquisition

16 Jul 2013

China detains four senior GSK employees over bribery

15 Jul 2013

Sun Pharma gets US nod to sell generic diabetes drug

13 Jul 2013

Swiss drugmaker Roche eyes Alexion Pharmaceuticals

13 Jul 2013

Anand Sharma seeks review of pharma sector FDI policy

12 Jul 2013

British drug regulator recalls 16 Wockhardt drugs

11 Jul 2013

China accuses GSK of bribery, raising prices and tax fraud

11 Jul 2013

Employees of GSK in China have confessed to bribing doctors, hospitals, government officials and others to prescribe the company's medicines to increase drug sales, China's ministry of public security said in a website statement

Ranbaxy to pay $0.42 million fine for sub-standard drugs sold in US

09 Jul 2013

GSK signs next-generation cancer drugs development deal with Immunocore

09 Jul 2013

Russia's biggest drugmaker Pharmstandard to spin off OTC business

09 Jul 2013

GSK probes whether employees bribed doctors in China to prescribe Botox

08 Jul 2013